Identifying risk of adverse outcomes in COVID-19 patients via artificial intelligence–powered analysis of 12-lead intake electrocardiogram

Por Arun R. Sridhar, MBBS, MPH, Zih-Hua Chen (Amber), MS, Jacob J. Mayfield, MD, Alison E. Fohner, PhD, Panagiotis Arvanitis, MD, Sarah Atkinson, BS, Frieder Braunschweig, MD, PhD, Neal A. Chatterjee, MD, MSc, Alessio Falasca Zamponi, MD, Gregory Johnson, PhD, Sanika A. Joshi, Mats C.H. Lassen, MD, Jeanne E. Poole, MD, FHRS, Christopher Rumer, BS, Kristoffer G. Skaarup, MD, Tor Biering-Sørensen, MD, PhD, MPH, Carina Blomstrom-Lundqvist, MD, PhD, Cecilia M. Linde, MD, PhD, Mary M. Maleckar, PhD, Patrick M. Boyle, PhD
Publicado em 2022-04-01